Patents by Inventor Soojin Kwon

Soojin Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR INHIBITING AGING OF STEM CELLS
    Publication number: 20260226417
    Abstract: The present invention relates to: a method for inhibiting aging of stem cells, comprising a step of treating stem cells with nervonic acid; and a composition for inhibiting aging of stem cells, containing nervonic acid as an active ingredient. According to the present invention, aging of aged stem cells can be restored such that high cell proliferation capacity and stem cell properties are maintained, and thus cell therapy efficacy using mesenchymal stem cells can be improved.
    Type: Application
    Filed: February 22, 2024
    Publication date: August 6, 2026
    Inventors: Hong Bae JEON, Sun Jeong KIM, Soojin KWON, Jae Hoon SONG
  • COMPOSITION FOR INDUCING DIFFERENTIATION OF MESENCHYMAL STEM CELLS INTO ADIPOCYTES
    Publication number: 20260226414
    Abstract: The present invention relates to: a method for differentiating mesenchymal stem cells into adipocytes, wherein mesenchymal stem cells are treated with nervonic acid; and a composition for inducing the differentiation of mesenchymal stem cells into adipocytes, the composition containing nervonic acid as an active ingredient. According to the present invention, mesenchymal stem cells can be differentiated into adipocytes with high efficiency, and thus the present invention is useful for producing adipocytes used in procedures for ameliorating skin wrinkles.
    Type: Application
    Filed: February 1, 2024
    Publication date: August 6, 2026
    Inventors: Hong Bae JEON, Sun Jeong KIM, Soojin KWON, Jae Hoon SONG
  • COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASES, CONTAINING STEM CELLS IN WHICH GRO-ALPHA IS EXPRESSED OR GRO-ALPHA
    Publication number: 20230416684
    Abstract: A cell death inhibitor including a mesenchymal stem cell genetically engineered to secrete growth-regulated oncogene-alpha (GRO-?) or overexpress GRO-? compared to a parent cell, GRO-?, or a combination thereof. A method of treating a muscle disease, including administering a pharmaceutically effective amount of a mesenchymal stem cell, which is genetically engineered to secrete growth-regulated oncogene-alpha (GRO-?) or overexpress GRO-? compared to a parent cell, or GRO-?, to a subject in need thereof.
    Type: Application
    Filed: November 9, 2021
    Publication date: December 28, 2023
    Applicants: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, ENCELL CO., LTD.
    Inventors: Jong Wook CHANG, Hong Bae JEON, Sang Eon PARK, Soojin KWON
  • Modulators of G protein-coupled receptor 88
    Patent number: 8497271
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: July 30, 2013
    Assignees: Bristol-Myers Squibb Company, Lexicon Pharmaceuticals, Inc.
    Inventors: Yingzhi Bi, Carolyn Diane Dzierba, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Li Dong, Cynthia Fink, Michael Green, David Kimball, John E. Macor, Soojin Kwon, Jiancheng Wang, Yulian Zhang, Greg Zipp
  • Modulators of G protein-coupled receptor 88
    Patent number: 8426414
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: April 23, 2013
    Assignees: Bristol-Myers Squibb Company, Lexicon Pharmaceuticals, Inc.
    Inventors: Yingzhi Bi, Carolyn Diane Dzierba, Joanne J. Bronson, Cynthia Fink, Michael Green, David Kimball, John E. Macor, Soojin Kwon, Yulian Zhang, Greg Zipp
  • Modulators of G protein-coupled receptor 88
    Patent number: 8304577
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Grant
    Filed: October 5, 2010
    Date of Patent: November 6, 2012
    Assignees: Bristol-Myers Squibb Company, Lexicon Pharmaceuticals, Inc.
    Inventors: Carolyn Diane Dzierba, Richard A. Hartz, Yingzhi Bi, Vijay T. Ahuja, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Michael Green, David Kimball, S. Roy Kimura, Soojin Kwon, John E. Macor, Yulian Zhang, Greg Zipp
  • Modulators of G Protein-Coupled Receptor 88
    Publication number: 20110251204
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Application
    Filed: October 4, 2010
    Publication date: October 13, 2011
    Inventors: Yingzhi Bi, Carolyn Diane Dzierba, Joanne J. Bronson, Cynthia Fink, Michael Green, David Kimball, John E. Macor, Soojin Kwon, Yulian Zhang, Greg Zipp
  • Modulators of G Protein-Coupled Receptor 88
    Publication number: 20110251196
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Application
    Filed: October 5, 2010
    Publication date: October 13, 2011
    Inventors: Carolyn Diane Dzierba, Richard A. Hartz, Yingzhi Bi, Vijay T. Ahuja, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Michael Green, David Kimball, S. Roy Kimura, Soojin Kwon, John E. Macor, Yulian Zhang, Greg Zipp
  • Modulators of G Protein-Coupled Receptor 88
    Publication number: 20110245264
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Application
    Filed: October 1, 2010
    Publication date: October 6, 2011
    Inventors: Yingzhi Bi, Carolyn Diane Dzierba, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Li Dong, Cynthia Fink, Michael Green, David Kimball, John E. Macor, Soojin Kwon, Jiancheng Wang, Yulian Zhang, Greg Zipp